Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Spectrum of Therapeutics and Confers Vulnerability to Replication Stress. Nyquist et al.
收藏官方服务：
资源简介：
These are the uncropped western blots used in figures 3 and 4
创建时间：
2020-05-14
